ID 404388783 · FY 2018–2024 · 7 years
Subsidiary of შეზღუდული პასუხისმგებლობისსაზოგადოება ფილუეტ საიპრეს ლიმიტედ (100.0%)
კომპანიის ძირითადი საქმიანობაა სხვადასხვა ბიოლოგიურად აქტიური საკვები დანამატების და თავის მოვლის საშუალებების იმპორტი და რეალიზაცია.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8,737 | 11,105 | 12,875 | 12,271 | 7,781 | 5,161 | 4,985 | -8.9% |
| Total COGS | -6,166 | -7,999 | -8,820 | -8,492 | -6,566 | -4,590 | -4,378 | -5.5% |
| Gross Profit | 2,570 | 3,107 | 4,055 | 3,779 | 1,214 | 571 | 607 | -21.4% |
| Gross Margin | 29.4% | 28.0% | 31.5% | 30.8% | 15.6% | 11.1% | 12.2% | |
| Other Operating Income | 0 | 0 | 0 | 48 | 0 | 65 | 0 | +16.0% |
| Total Operating Expenses | -920 | -1,086 | -1,170 | -1,101 | -654 | -1,156 | -920 | +0.0% |
| EBITDA | 1,650 | 2,020 | 2,885 | 2,726 | 561 | -520 | -314 | nmf |
| EBITDA Margin | 18.9% | 18.2% | 22.4% | 22.2% | 7.2% | -10.1% | -6.3% | |
| Total D&A | -4 | -125 | -138 | -189 | -527 | -549 | -414 | nmf |
| Impairment (non-financial) | 0 | 0 | 0 | 0 | 0 | -202 | 0 | |
| EBIT / Operating Income | 1,647 | 1,896 | 2,747 | 2,537 | 34 | -1,271 | -727 | nmf |
| Total Interest Expense | 0 | -23 | -16 | -65 | -70 | -61 | -133 | +42.1% |
| Total Other Income | -115 | -348 | 304 | -189 | 96 | 0 | 2 | nmf |
| Profit Before Tax | 1,532 | 1,525 | 3,035 | 2,283 | 60 | -1,333 | -859 | nmf |
| Total Income Tax | -188 | -209 | -458 | -222 | -305 | 0 | 0 | +12.9% |
| Net Profit / (Loss) | 1,344 | 1,415 | 2,577 | 2,061 | -245 | -1,333 | -859 | nmf |
| Net Margin | 15.4% | 12.7% | 20.0% | 16.8% | -3.2% | -25.8% | -17.2% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 ₾1.7m · FY2023 ₾0 · FY2024 ₾0 — 3-yr total ₾1.7m
Ownership & directors from companyinfo.ge (public corporate registry).